FindTrial
Sign In

Goshajinkigan for chemotherapy-induced peripheral neuropathy control : A systematic review

Goshajinkigan for chemotherapy-induced peripheral neuropathy control : A systematic review - GCPNC

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000037226
Enrollment
100
Registered
2022-12-01
Start date
2019-02-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced peripheral neuropathy

Interventions

None listed

Sponsors

Yokohama University of Pharmacy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: An outcome report of peripheral neuropathy induced by cancer chemotherapy

Exclusion criteria

Exclusion criteria: Report on peripheral neuropathy induced by other than cancer chemotherapy as outcome

Design outcomes

Primary

MeasureTime frame
Evaluation index of peripheral neuropathy 1. CTCAE 2. DEB-NTC—

Countries

Japan

Contacts

Public ContactKohsuke Hayamizu

Yokohama University of Pharmacy Dep. of Pharmacy

k.hayamizu@hamayaku.ac.jp045-859-1300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026